← All State Street CORP filings

State Street CORP Schedule 13G passive stakes

NYSE
STT
State Street CORP
SCHEDULE: State Street Reports 5.3% Stake in Corvus Pharma
State Street Corporation has disclosed beneficial ownership of 5.3% of Corvus Pharmaceuticals Inc.'s common stock as of June 30, 2026.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses Stake in Contango Silver & Gold
State Street Corporation and SSGA Funds Management, Inc. have reported a combined beneficial ownership of 7.6% in Contango Silver & Gold Inc. as of June 30, 2026.
NYSE
STT
State Street CORP
SCHEDULE: State Street Reports Stake in Conagra Brands
State Street Corporation has updated its beneficial ownership filing for Conagra Brands Inc., reporting a 3.5% stake.
NYSE
STT
State Street CORP
SCHEDULE: State Street Reports 5.5% Stake in Compass Therapeutics
State Street Corporation has disclosed beneficial ownership of 5.5% of Compass Therapeutics' common stock as of June 30, 2026.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses Commerce Bancshares Stake
State Street Corporation has filed a Schedule 13G, reporting its beneficial ownership of Commerce Bancshares Inc./MO common stock as of June 30, 2026.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses 5.5% Stake in Cogent Communications
State Street Corporation has reported beneficial ownership of 5.5% of Cogent Communications Holdings Inc.'s common stock as of June 30, 2026.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses 5.8% Stake in Cleveland-Cliffs
State Street Corporation has reported beneficial ownership of 5.8% of Cleveland-Cliffs Inc. common stock as of June 30, 2026.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses 5.4% Stake in City Holding Co
State Street Corporation has reported a beneficial ownership of 5.4% in City Holding Co. common stock as of June 30, 2026.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses 5% Stake in Citizens Financial
State Street Corporation has reported beneficial ownership of approximately 5% of Citizens Financial Group's common stock as of June 30, 2026.
NYSE
STT
State Street CORP
SCHEDULE: State Street Reports 5% Stake in Cisco
State Street Corporation has disclosed beneficial ownership of approximately 5% of Cisco Systems Inc.'s common stock as of June 30, 2026.
NYSE
STT
State Street CORP
SCHEDULE: State Street Reports 5.4% Stake in Champion Homes
State Street Corporation has disclosed beneficial ownership of 5.4% of Champion Homes Inc.'s common stock as of June 30, 2026.
NYSE
STT
State Street CORP
SCHEDULE: State Street Reports 6% Stake in CEVA Inc.
State Street Corporation has disclosed beneficial ownership of 6% of CEVA Inc.'s common stock as of June 30, 2026.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses Stake in Century Communities
State Street Corporation has filed a Schedule 13G, reporting beneficial ownership of 5% of Century Communities Inc. common stock as of June 30, 2026.
NYSE
STT
State Street CORP
SCHEDULE: State Street Corp. Discloses Century Aluminum Stake
State Street Corporation has updated its beneficial ownership filing for Century Aluminum Co., reporting a 5.6% stake.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses Centrus Energy Stake
State Street Corporation and its affiliate SSGA Funds Management, Inc. have reported beneficial ownership of 8.6% and 6.5% respectively in Centrus Energy Corp.
NYSE
STT
State Street CORP
SCHEDULE: State Street Reports Carlisle Stake
State Street Corporation has updated its beneficial ownership filing for Carlisle Companies Inc., now holding 5.2% of the common stock.
NYSE
STT
State Street CORP
SCHEDULE: State Street Reports 4.8% Stake in CareDx
State Street Corporation has disclosed beneficial ownership of 4.8% of CareDx Inc.'s common stock as of June 30, 2026.
NYSE
STT
State Street CORP
SCHEDULE: State Street Corp. Discloses Stake in Capricor Therapeutics
State Street Corporation has reported beneficial ownership of 5.9% of Capricor Therapeutics Inc.'s common stock as of June 30, 2026.
NYSE
STT
State Street CORP
SCHEDULE: State Street Reports 5% Stake in Capitol Federal Financial
State Street Corporation has reported beneficial ownership of 5% of Capitol Federal Financial Inc.'s common stock as of June 30, 2026.
NYSE
STT
State Street CORP
SCHEDULE: State Street Reports BTCS Inc. Stake
State Street Corporation and SSGA Funds Management, Inc. have updated their beneficial ownership filing for BTCS Inc. common stock, reporting a combined holding of 160,000 shares.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses Broadstone Net Lease Stake
State Street Corporation has filed a Schedule 13G, reporting beneficial ownership of 5.6% of Broadstone Net Lease Inc.'s common stock as of June 30, 2026.
NYSE
STT
State Street CORP
SCHEDULE: State Street Reports Bristol-Myers Squibb Stake
State Street Corporation has updated its beneficial ownership filing for Bristol-Myers Squibb, reporting a significant aggregate holding.
NYSE
STT
State Street CORP
SCHEDULE: State Street Reports 5% Stake in Black Hills Corp
State Street Corporation has disclosed beneficial ownership of 5% of Black Hills Corp's common stock as of June 30, 2026.
NYSE
STT
State Street CORP
SCHEDULE: State Street Corp. Discloses Stake in BioCryst Pharmaceuticals
State Street Corporation has updated its Schedule 13G filing to reflect its beneficial ownership of 15,191,098 shares, or approximately 6%, of BioCryst Pharmaceuticals Inc. common stock as of June 30, 2026.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses Becton Dickinson Stake
State Street Corporation has updated its beneficial ownership filing for Becton Dickinson & Co., reporting a significant stake.
NYSE
STT
State Street CORP
SCHEDULE: State Street Reports Ball Corp Stake
State Street Corporation has updated its beneficial ownership filing for Ball Corp, reporting a significant stake in the company's common stock.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses 5.3% Stake in Axos Financial
State Street Corporation has reported beneficial ownership of 5.3% of Axos Financial Inc.'s common stock as of June 30, 2026.
NYSE
STT
State Street CORP
SCHEDULE: State Street Reports 5.3% Stake in Avery Dennison
State Street Corporation has disclosed beneficial ownership of 5.3% of Avery Dennison Corp.'s common stock as of June 30, 2026.
NYSE
STT
State Street CORP
SCHEDULE: State Street Reports 5.5% Stake in Avalo Therapeutics
State Street Corporation has disclosed beneficial ownership of 5.5% of Avalo Therapeutics Inc.'s common stock as of June 30, 2026.
NYSE
STT
State Street CORP
SCHEDULE: State Street Reports 5.1% Stake in ADP
State Street Corporation has disclosed beneficial ownership of 5.1% of Automatic Data Processing Inc. common stock as of June 30, 2026.